Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China · Delayed Price · Currency is CNY 4.430
+0.010 (0.23%)
Feb 4, 2026, 1:25 PM CST
SHE:300194 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 144.49 | 279.84 | 231.87 | 204.61 | -296.91 | 209.37 |
Depreciation & Amortization | 198.26 | 198.26 | 209.07 | 184.43 | 174.29 | 155.78 |
Other Amortization | 0.96 | 0.96 | 0.72 | 0.97 | 0.7 | 0.81 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -220.65 | -4.85 | -0.31 | -1 |
Asset Writedown & Restructuring Costs | 37.77 | 37.77 | 228.06 | 25.41 | 827.23 | 2.69 |
Loss (Gain) From Sale of Investments | -77.37 | -77.37 | -77.8 | -62.16 | -52.47 | -39.84 |
Provision & Write-off of Bad Debts | 3.96 | 3.96 | -2.43 | 3.68 | 4.27 | -1.78 |
Other Operating Activities | 49.58 | 54.05 | 44.66 | 46.76 | -286.2 | 13.21 |
Change in Accounts Receivable | 46.84 | 46.84 | 71.85 | -78.5 | -68.26 | -75.1 |
Change in Inventory | -182.31 | -182.31 | 9.2 | -120.85 | -65.3 | -119.29 |
Change in Accounts Payable | -72.15 | -72.15 | -193.15 | 159.88 | 24.98 | 24.92 |
Change in Other Net Operating Assets | 10.07 | 10.07 | 4.8 | 4.4 | - | - |
Operating Cash Flow | 163.78 | 303.59 | 328.98 | 339.5 | 257.13 | 162.55 |
Operating Cash Flow Growth | -64.55% | -7.72% | -3.10% | 32.04% | 58.18% | -45.01% |
Capital Expenditures | -170.44 | -241.79 | -215.68 | -383.1 | -413.03 | -344.53 |
Sale of Property, Plant & Equipment | 5.45 | 0.3 | 122.67 | 4.28 | 31.49 | 71.12 |
Cash Acquisitions | - | - | - | - | -1 | -201.16 |
Divestitures | -4.63 | -4.63 | - | -0.06 | - | - |
Investment in Securities | -79.81 | -54.81 | -1.25 | -71.43 | 32.38 | 52.23 |
Other Investing Activities | 39.37 | 36.1 | 0.64 | 10.31 | 0.94 | 105.51 |
Investing Cash Flow | -210.07 | -264.83 | -93.62 | -440.01 | -349.24 | -316.84 |
Short-Term Debt Issued | - | 83.04 | - | 49.28 | - | - |
Long-Term Debt Issued | - | 485.09 | 848.08 | 588.56 | 964.75 | 643.2 |
Total Debt Issued | 973.56 | 568.13 | 848.08 | 637.84 | 964.75 | 643.2 |
Short-Term Debt Repaid | - | -37 | - | - | - | - |
Long-Term Debt Repaid | - | -666.25 | -706.06 | -802.42 | -683 | -205.22 |
Total Debt Repaid | -792.29 | -703.25 | -706.06 | -802.42 | -683 | -205.22 |
Net Debt Issued (Repaid) | 181.28 | -135.12 | 142.02 | -164.58 | 281.75 | 437.98 |
Common Dividends Paid | -105.09 | -84.22 | -93.98 | -28.09 | -84.11 | -72.71 |
Other Financing Activities | 40.93 | -8.59 | -1.78 | 20.99 | 13.77 | -38.29 |
Financing Cash Flow | 117.12 | -227.93 | 46.25 | -171.68 | 211.41 | 326.98 |
Foreign Exchange Rate Adjustments | 0.76 | 0.91 | 0.88 | 2.91 | -2.17 | -13.73 |
Net Cash Flow | 71.59 | -188.26 | 282.49 | -269.27 | 117.13 | 158.97 |
Free Cash Flow | -6.66 | 61.8 | 113.3 | -43.6 | -155.91 | -181.98 |
Free Cash Flow Growth | - | -45.46% | - | - | - | - |
Free Cash Flow Margin | -0.39% | 2.58% | 4.28% | -1.80% | -6.35% | -7.68% |
Free Cash Flow Per Share | -0.01 | 0.05 | 0.09 | -0.04 | -0.13 | -0.16 |
Cash Income Tax Paid | 143.1 | 202.61 | 198.28 | 155.41 | 190.43 | 213.76 |
Levered Free Cash Flow | -95.72 | -37.48 | 98.2 | -60.74 | -139.3 | 46.66 |
Unlevered Free Cash Flow | -81.75 | -22.89 | 116.68 | -43.91 | -126.52 | 53.01 |
Change in Working Capital | -193.86 | -193.86 | -84.51 | -59.35 | -113.48 | -176.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.